Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development.

Pal S, Gupta R, Kim H, Wickramasinghe P, Baubet V, Showe LC, Dahmane N, Davuluri RV.

Genome Res. 2011 Aug;21(8):1260-72. doi: 10.1101/gr.120535.111. Epub 2011 Jun 28.

2.

Alternative transcription and alternative splicing in cancer.

Pal S, Gupta R, Davuluri RV.

Pharmacol Ther. 2012 Dec;136(3):283-94. doi: 10.1016/j.pharmthera.2012.08.005. Epub 2012 Aug 14. Review.

PMID:
22909788
3.

Cerebellum development and medulloblastoma.

Roussel MF, Hatten ME.

Curr Top Dev Biol. 2011;94:235-82. doi: 10.1016/B978-0-12-380916-2.00008-5. Review.

4.

Alternative mRNA transcription, processing, and translation: insights from RNA sequencing.

de Klerk E, 't Hoen PA.

Trends Genet. 2015 Mar;31(3):128-39. doi: 10.1016/j.tig.2015.01.001. Epub 2015 Jan 30. Review.

PMID:
25648499
5.

Alternative intronic promoters in development and disease.

Vacik T, Raska I.

Protoplasma. 2017 May;254(3):1201-1206. doi: 10.1007/s00709-016-1071-y. Epub 2017 Jan 11. Review.

PMID:
28078440
6.

From immunogenetics to immunomics: functional prospecting of genes and transcripts.

Schönbach C.

Novartis Found Symp. 2003;254:177-88; discussion 189-92, 216-22, 250-2. Review.

PMID:
14712938
7.

Complexity of the alternative splicing landscape in plants.

Reddy AS, Marquez Y, Kalyna M, Barta A.

Plant Cell. 2013 Oct;25(10):3657-83. doi: 10.1105/tpc.113.117523. Epub 2013 Oct 31. Review.

8.

mRNA transcript diversity creates new opportunities for pharmacological intervention.

Barrie ES, Smith RM, Sanford JC, Sadee W.

Mol Pharmacol. 2012 May;81(5):620-30. doi: 10.1124/mol.111.076604. Epub 2012 Feb 7. Review.

9.

The emerging era of genomic data integration for analyzing splice isoform function.

Li HD, Menon R, Omenn GS, Guan Y.

Trends Genet. 2014 Aug;30(8):340-7. doi: 10.1016/j.tig.2014.05.005. Epub 2014 Jun 17. Review.

10.

Processing and transcriptome expansion at the mRNA 3' end in health and disease: finding the right end.

Ogorodnikov A, Kargapolova Y, Danckwardt S.

Pflugers Arch. 2016 Jun;468(6):993-1012. doi: 10.1007/s00424-016-1828-3. Epub 2016 May 25. Review.

11.

Genome stability versus transcript diversity.

Magnuson B, Bedi K, Ljungman M.

DNA Repair (Amst). 2016 Aug;44:81-6. doi: 10.1016/j.dnarep.2016.05.010. Epub 2016 May 16. Review.

PMID:
27246512
12.

Functional consequences of developmentally regulated alternative splicing.

Kalsotra A, Cooper TA.

Nat Rev Genet. 2011 Sep 16;12(10):715-29. doi: 10.1038/nrg3052. Review.

13.

Alternative splicing and biological heterogeneity in prostate cancer.

Rajan P, Elliott DJ, Robson CN, Leung HY.

Nat Rev Urol. 2009 Aug;6(8):454-60. doi: 10.1038/nrurol.2009.125. Review.

PMID:
19657379
14.

A survey of computational methods in transcriptome-wide alternative splicing analysis.

Wang J, Ye Z, Huang TH, Shi H, Jin V.

Biomol Concepts. 2015 Mar;6(1):59-66. doi: 10.1515/bmc-2014-0040. Review.

15.

Building robust transcriptomes with master splicing factors.

Jangi M, Sharp PA.

Cell. 2014 Oct 23;159(3):487-98. doi: 10.1016/j.cell.2014.09.054. Review.

16.

WOMEN IN CANCER THEMATIC REVIEW: Diverse functions of DNA methylation: implications for prostate cancer and beyond.

Sweet TJ, Ting AH.

Endocr Relat Cancer. 2016 Nov;23(11):T169-T178. Epub 2016 Sep 7. Review.

17.

Alternative splicing and the evolution of phenotypic novelty.

Bush SJ, Chen L, Tovar-Corona JM, Urrutia AO.

Philos Trans R Soc Lond B Biol Sci. 2017 Feb 5;372(1713). pii: 20150474. Review.

PMID:
27994117
18.

Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.

Gallego-Paez LM, Bordone MC, Leote AC, Saraiva-Agostinho N, Ascensão-Ferreira M, Barbosa-Morais NL.

Hum Genet. 2017 Apr 3. doi: 10.1007/s00439-017-1790-y. [Epub ahead of print] Review.

PMID:
28374191
19.

Advances in analyzing RNA diversity in eukaryotic transcriptomes: peering through the Omics lens.

Bangru S, Kalsotra A.

F1000Res. 2016 Nov 14;5:2668. eCollection 2016. Review.

20.

What Is the Impact of mRNA 5' TL Heterogeneity on Translational Start Site Selection and the Mammalian Cellular Phenotype?

Curran JA, Weiss B.

Front Genet. 2016 Aug 31;7:156. doi: 10.3389/fgene.2016.00156. eCollection 2016. Review.

Supplemental Content

Support Center